Vapor Corp. (VPCO) shares are up close to 32% to about $3.71 in mid-day trading Tuesday. Not seeing any news to account for the move, but the climb looks supported by Friday’s press release. Approximately 16M shares have already changed hands, compared to the stock’s average daily volume of 528,852 shares.
During the trading session, VPCO gapped open sharply higher Tuesday and climbed for the majority of the morning, before settling into an intraday range of $3.46 to $3.74 with its 52-week range being $1.02 to $10.00.
Vapor Corp. shares have a t-12 price/sales ratio of 1.91. Price/book for the same period is 4.57, while EPS is ($0.12). Vapor Corp has a market cap of $55.13M and a median Wall Street price target of $5.50.
Shares of the electronic cigarettes distributor are up 324 percent year-over-year.
Analysts at MLV & Co upgraded shares of Cytokinetics, Inc (CYTK) to ‘Buy’ and lifted their price target to $9 from $5 in a research report issued to investors on Tuesday. The firm cited Cytokinetics’ completed review of its Phase II BENEFIT-ALS trial results and concluded that one of the endpoints, slow vital capacity (SVC), provided meaningful clinical benefit. MLV& Co’s new price target points to a potential upside of 108% from the stock’s current pps.
Cytokinetics gained $0.63 to $4.33 in mid-day trading today. Approximately 816,116 shares have already changed hands ; nearly 3x the name’s average daily volume of 354,568 shares.
On valuation-measures, shares of Cytokinetics Incorporated have a P/E to growth ratio of (0.25) and a t-12 profit margin of (33.43%). EPS registers at ($0.49). The company has a market cap of $158.52M and a median Wall Street price target of $13.00 with a high target of $15.00.
On trading-measure, CYTK has a beta of 1.84 and a short float of 5.76%. In the past 52 weeks, shares of the clinical stage biopharmaceutical company have traded between a low of $3.05 and a high of $13.26 with the 50-day MA and 200-day MA located at $3.56 and $4.46 levels, respectively.
CYTK currently prints a one year loss of about 38.64%, and a year-to-date loss of around 43.08%.
Shares of YOU On Demand Holdings, Inc. (YOD) are up 20%. The surge is being attributed to a Reuters story that Xiaomi will invest $1 billion to expand its internet TV content. The speculation is that YOD will partner with Xiaomi on the initiative.
YOU On Demand is currently valued at $54.25M. Approximately 1,36M shares have already changed hands, compared to the stock’s average daily volume of 241,069 shares.
In the past 12 months, shares of the Chinese streaming video service have traded between a low of $1.61 and a high of $7.35 with the 50-day MA and 200-day MA located at $1.87 and $2.54 levels, respectively.
YOD currently prints a one year return of about 0.57%, and a year-to-date loss of around 22.57%.